Nifedipine and Jaundice cholestatic - a phase IV clinical study of FDA data

Summary:

Jaundice cholestatic is found among people who take Nifedipine, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Nifedipine and have Jaundice cholestatic. It is created by eHealthMe based on reports of 45,590 people who have side effects when taking Nifedipine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 24, 2023

45,590 people reported to have side effects when taking Nifedipine.
Among them, 31 people (0.07%) have Jaundice cholestatic.

What is Nifedipine?

Nifedipine has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 46,360 Nifedipine users for its effectiveness, alternative drugs and more.

What is Jaundice cholestatic?

Jaundice cholestatic is found to be associated with 1,525 drugs and 930 conditions by eHealthMe.

Number of Nifedipine and Jaundice cholestatic reports submitted per year:

Could Nifedipine cause Jaundice cholestatic?

Gender of people who have Jaundice cholestatic when taking Nifedipine *:

female: 12.9 %
male: 87.1 %

Age of people who have Jaundice cholestatic when taking Nifedipine *:

Common drugs people take besides Nifedipine *:

Common side effects people have besides Jaundice cholestatic *:

Liver Disorder (liver diseases): 13 people, 41.94%
Ascites (accumulation of fluid in the abdominal cavity): 13 people, 41.94%
Nausea (feeling of having an urge to vomit): 13 people, 41.94%
Nausea And Vomiting: 13 people, 41.94%
Breathing Difficulty: 12 people, 38.71%
Bilirubin Conjugated Increased: 12 people, 38.71%
Pain: 12 people, 38.71%
Portal Hypertension (increase in the blood pressure within a system of veins called the portal venous system): 12 people, 38.71%
Aspartate Aminotransferase Increased: 12 people, 38.71%
Rectal Haemorrhage (bleeding from anus): 12 people, 38.71%

Common conditions people have *:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 8 people, 25.81%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 9.68%
Lower Respiratory Tract Infection: 2 people, 6.45%
Type 2 Diabetes: 1 person, 3.23%
Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 3.23%
Neuropathic Pain (pain due to nerve inflammation and damage): 1 person, 3.23%
Gastric Cancer (stomach cancer): 1 person, 3.23%
Diabetes: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Nifedipine and have Jaundice cholestatic?

Check whether Jaundice cholestatic is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Agrawal A, Rao M, Jasdanwala S, Mathur A, Eng M, "Cephalexin Induced Cholestatic Jaundice", Case reports in gastrointestinal medicine, 2014 Aug .

Related studies

How severe was Jaundice cholestatic and when was it recovered:

Jaundice cholestatic in Nifedipine

Expand to all the drugs that have ingredients of nifedipine:

Jaundice cholestatic and drugs with ingredients of nifedipine (71 reports)

Alternative drugs to, pros and cons of Nifedipine:

Nifedipine (46,360 reports)

Common Nifedipine side effects:

High blood pressure: 3,068 reports
Breathing difficulty: 2,587 reports
Fatigue (feeling of tiredness): 2,376 reports
Drug ineffective: 2,299 reports
Hypotension (abnormally low blood pressure): 2,265 reports
Diarrhea: 2,204 reports
Weakness: 2,149 reports

Browse all side effects of Nifedipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Jaundice cholestatic treatments and more:

Jaundice cholestatic (4,754 reports)

COVID vaccines that are related to Jaundice cholestatic:

Common drugs associated with Jaundice cholestatic:

All the drugs that are associated with Jaundice cholestatic:

Jaundice cholestatic (1,525 drugs)

Common conditions associated with Jaundice cholestatic:

All the conditions that are associated with Jaundice cholestatic:

Jaundice cholestatic (930 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine (the active ingredients of Nifedipine) and Nifedipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.